Wragge Lawrence Graham & Co
- Litigation / Dispute Resolution (10)
- Company/Commercial (8)
- Employment (7)
- Intellectual Property (5)
- Pharma/Biotech (5)
- Corporate (4)
- Public Sector/Local Authority (4)
- Regulatory and compliance (4)
- Information Technology (3)
- Clinical/Medical Negligence (2)
- Competition/EU (2)
- Energy (2)
- In-House (2)
- Transport (Including aviation and shipping) (2)
- Banking / Finance (1)
- Financial services (1)
- Human Rights (1)
- Insurance/reinsurance (1)
- Pensions (1)
- Real Estate (1)
- Telecoms (1)
Sort By: Newest first | Oldest first
SPCs and combination products: basic patent on a sole ingredient cannot double as basic patent for combination
On 12 March 2015 the CJEU gave its ruling in Actavis v Boehringer Ingelheim, yet another reference from the UK courts regarding the interpretation of the SPC Regulation 469/2009.
It has never been more crucial for both contracting authorities and suppliers to ensure they are familiar with the changes brought about by the Public Contracts Regulations 2015.
Arnold J has delivered a solution to the issue of a patent with claims in the ‘Swiss form’ but this is unlikely to be the last word in the saga. Life sciences companies – watch this space.
Wragges has advised long-standing client on a three-year drug discovery collaboration agreement with Orca.
Birss J rules on product by process claim construction, extension of scope, added matter and obviousness in Hospira v Genentech.
In Teva v Leo, Mr Justice Birss was asked to decide whether two patents relating to a combined formulation for treatment of psoriasis were valid and infringed.
Wragge Lawrence Graham & Co has advised Formation Capital on its acquisition of NHP for a consideration of £477m.
People have responded to the technological revolution by working longer hours and refusing to leave the office behind even when they can be prised from the desk.
Wragge Lawrence Graham & Co’s public law and regulation expert Ravi Randhawa has been promoted to the role of legal director.
Does the fact that a person is obese mean they are, or could be, ‘disabled’ for the purposes of the Equality Act 2010?
Wragge Lawrence Graham & Co has advised biopharmaceutical company arGEN-X on its first collaboration with Bayer and on a strategic alliance with Shire.
The Court of Appeal has unanimously held that a parent company was not liable for industrial disease suffered by an employee of a subsidiary.
In a recent Technical Board of Appeal decision, the European Patent Office has shed some light upon the boundaries of the prohibition against double patenting.
In Rose, the Administrative Court considered whether a CCG had acted unlawfully in failing to follow guidance issued by NICE.
In February 2013, the European Commission released a draft Network and Information Security Directive.
Allowing independent providers into the NHS Pension Scheme — tackling recruitment issues and facilitating the movement of staff
From 1 April 2014, an independent provider who meets the relevant eligibility criteria will be able to apply to become an employing authority in the NHS Pension Scheme.
Part of the cross-government Health, Work and Wellbeing initiative, the ‘Health and Work Service’ will provide occupational health advice and support for employers and employees.
There may be circumstances when disclosure of a party’s insurance arrangements can be ordered by the court
A group of litigants has been granted an order for disclosure of a defendant’s insurance arrangements in respect of the defendant’s potential liability in the litigation.
Will dismissal always fall within the range of reasonable responses where gross misconduct is found?
Does the fact that a person is obese mean they are, or could be, ‘disabled’? The CJEU has been asked by Denmark whether discrimination on the grounds of obesity is contrary to EU law.